Quick Takeaways
- 5AM Opportunities II (GP), LLC filed SCHEDULE 13G for Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (ZNTL).
- Disclosed ownership: 6.4%.
- Date of event: 18 Dec 2025.
Quoteable Key Fact
"5AM Opportunities II (GP), LLC disclosed 6.4% ownership in Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (ZNTL) on 18 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 5AM Opportunities II (GP), LLC | 5.2% | 3,947,913 | 0 | 3,947,913 | /s/ Andrew J. Schwab | By Andrew J. Schwab, Managing Member | |
| 5AM Opportunities II, L.P. | 5.2% | 3,947,913 | 0 | 3,947,913 | /s/ Andrew J. Schwab | By 5AM Opportunities II (GP), LLC, its General Partner, By Andrew J. Schwab, Managing Member | |
| 5AM Opportunities (GP), LLC | 1.2% | 890,658 | 0 | 890,658 | /s/ Andrew J. Schwab | By Andrew J. Schwab, Managing Member | |
| 5AM Opportunities Master Fund L.P. | 1.2% | 890,658 | 0 | 890,658 | /s/ Andrew J. Schwab | By 5AM Opportunities II (GP), LLC, its General Partner, By Andrew J. Schwab, Managing Member | |
| Andrew J. Schwab | 6.4% | 4,838,571 | 0 | 4,838,571 | /s/ Andrew J. Schwab | Andrew J. Schwab | |
| Kush Parmar | 6.4% | 4,838,571 | 0 | 4,838,571 | /s/ Kush Parmar | Kush Parmar | |
| Anna Yaeger | 1.2% | 890,658 | 0 | 890,658 | /s/ Anna Yaeger | Anna Yaeger |